During automated (APR), it can be challeng\x02ing to synthesize correct patches for real-world systems in general-purpose ...

Reimaging professional and educational practices for an AI-augmented future.

OpenAI’s AI video generator Sora is officially done, less than a year after it went viral. At first glance, it’s easy to ...

Generate Biomedicines has completed its IPO, raising an impressive $400 million that makes it the largest listing for a biotech on the Nasdaq so far this year. Incubated by investment group Flagship ...

Most Android projects don’t fail because of bad developers. They fail because of bad technology decisions. If your mobile app development is taking too long,...Read More The post Kotlin vs Java in ...

UC San Diego cognitive scientist Philip Guo created Python Tutor, a free tool that makes code “visible” step by step. The ...

Explore the key differences between vibe coding and traditional coding. Learn how AI driven prompt creation compares to ...

Cortex 3.0 delivers AI-powered code generation, vulnerability scanning, Enterprise AI & DevSecOps integrations, ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

(Bloomberg) --Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer ...